Bionano Genomics (NASDAQ:BNGO) Earns Buy Rating from Analysts at HC Wainwright
Equities researchers at HC Wainwright initiated coverage on shares of Bionano Genomics (NASDAQ:BNGO – Get Free Report) in a research report issued on Wednesday, Marketbeat reports. The firm set a “buy” rating and a $10.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 127.27% from the stock’s previous close. […]
